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Polycystic ovary syndrome (PCOS) is a common endocrine disorder 
and is a major cause of an ovulatory infertility. The main objective is to 
estimate the prevalence of PCOS in the region of Pollog, Republic of 
Macedonia and to assess some clinical and biochemical parameters in 
patients with PCOS in comparison with normal women as control. 
Rotterdam criteria is used to evaluate 70 women diagnosed with PCOS, 
compared to 30 age matched controls to assess the clinical and biochemical 
abnormalities that occur in PCOS patients. All statistical analysis is done 
using SPSS (version 19.0). A P-value < 0.05 is considered statistically 
significant. Mean age in PCOS group is 25.11 ± 3.32, and 25.10 ± 3.91 in the 
control group. BMI of the women with PCOS is significantly higher than in 
the control group. Menstrual cycle abnormalities are observed in 71.4% of 
PCOS patients, and ultrasonographic appearance of polycystic ovaries is 
reported for all PCOS cases. Hirsutism (FG 8-9) is present in 42.9 %, 
hirsutism (FG 10-14) in 50% and 7.1% showed hirsutism (FG>15). We 
recorded significantly higher serum levels of luteinizing hormone (LH), total 
testosterone (TT), and insulin, while the serum levels of sex hormone 
binding globuline (SHBG) and follicular stimulating hormone (FSH) are 
significantly lower than in the control group. By analyzing the clinical and 
biochemical characteristics of our studied population of patients with PCOS, 
we can conclude that the majority of our patients expressed all three 
diagnostic features of PCOS (hyperandrogenism, menstrual abnormalities, 
and ultrasound findings of polycystic ovaries).  
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Introduction 
POLYCYSTIC OVARY SYNDROME (PCOS) is a heterogeneous 
disorder, characterized by chronic an ovulation and hyperandrogenism. It 
affects between 5 to10% of women of reproductive age, and it is considered 
one of the most common endocrine disorders in premenopausal women 
(Knochenhauser ES. et al, 1998). 
PCOS manifests itself with an array of clinical features and 
symptoms, the three most common being: disorders of ovulation, excessive 
production of androgens, and polycystic ovaries on ultrasound. PCOS is 
often associated with obesity and insulin resistance. For a number of years 
PCOS has been associated with skin and reproductive manifestations. 
However, this syndrome became very interesting to the medical community 
in the 1980‘s, when it is found that women with PCOS have a higher risk of 
obesity, insulin resistance, glucose intolerance, type 2 diabetes mellitus, 
dyslipidemia, hypertension, and metabolic syndrome ( Eggers S, et al, 2001). 
The heterogeneity in the clinical signs of PCOS and the lack of 
uniformity in its defining symptoms hamper diagnosis. In recent years, 
specialists have attempted to reach a consensus regarding the definition of 
diagnostic criteria. In 1990, the National Institutes of Health (NIH) 
established that a diagnosis of PCOS required the simultaneous presence of 
two clinical criteria: oligoovulation or an ovulation and clinical and/or 
biochemical hyperandrogenism, after all other possible etiologies had been 
excluded. In 2003, the Rotterdam Consensus (RC), sponsored by the 
European Society for Human Reproduction and Embryology and the 
American Society for Reproductive Medicine, stipulated that at least two of 
the following three criteria should be present: oligoovulation or an ovulation, 
clinical and/or biochemical hyperandrogenism and ultrasonographically 
detected polycystic ovaries, after the exclusion of all other possible 
etiologies (Group PCW 2003). Ovulation disorders usually become apparent 
in the form of oligomenorrhea, although about 20–30% of women with 
PCOS with oligomenorrhea have eumenorrhea (subclinical oligomenorrhea). 
Excessive production of androgens or hyperandrogenism (HA) is confirmed 
via laboratory analysis, characterized by elevated values of circulating 
androgens, or on the basis of clinical signs, primarily in the form of 
hirsutism. In the past, polycystic ovaries are determined on the basis of 
histopathological analysis, however, today evidence of polycystic ovaries on 
an ultrasound examination is sufficient. The ethnicity of patients influences 
the extent of this signs and symptoms, especially with regard to hirsutism 
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and obesity (Richardson MR, 2003). Therefore, the frequency of symptoms 
varies between different countries and ethnic groups. 
In the light of this background the current study is conducted to 
estimate the prevalence of PCOS in the region of Pollog, Republic of 
Macedonia and to shed light on some biochemical parameters in patients 
with PCOS to reach some aspects of its pathogenesis through a comparison 
with normal women as control. 
 
Materials and Methods: 
Study population 
Women attending the specialized gynecology ambulance Gyneco-
Medica – Tetovo and gynecology hospital-Tetovo, diagnosed of PCOS 
according to the Rotterdam ESHRE/ASRM criteria (N=70), are included in 
the study.   Age, and anthropometric measurements like height (in cm) and 
weight (in kg) and waist and hip circumference (in cm) is measured. BMI is 
calculated using the formula BMI= waist (in kg) x height (in m
2
), and in the 
same time waist to hip ratio WHI is calculated as well. Diagnosis of PCOS is 
based on the presence of hirsutism by the presence of excessive body hair 
distributed in an androgen-depend pattern, using Ferriman-Gallwey index 
score (FG) and/or hyperandrogenemia and menstrual dysfunction. Women 
with other endocrine pathologies which may give similar signs as PCOS are 
exluded from the study according to the results from appropriated tests made 
for 17-hydroxyprogesterone, prolactin, thyroid stimulating hormone (TSH) 
and cortisol. None of the patients had other diseases or are taking any 
medication for at least 6 months prior to the study. In the control group, we 
included 30 patients, who had no disorders of the menstrual cycle without 
clinical biochemical signs of hyperandrogenism and without ultrasound 
findings of polycystic ovaries.  
 
Biochemical analysis 
Blood samples are collected from all subjects in the early follicular 
phase of a spontaneous or progesterone induced menstrual cycle (day 3-5). 
The levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), 
total testosterone, sex homone binding globuline (SHBG), glucose and 
insulin are measured in the peripheral blood. Insulin sensitivity HOMA-IR is 
calculated according to the formula (insulin(mU/L x glucose (mmol/L)) / 
22.5) (Ascaso JF et al, 2003). We defined insulin resistance as HOMA-IR ≥ 
2.5 (Azziz R. et al, 2006).  
 
Statistical analysis 
The categorical variables are described by percentages, and the 
continuous as mean ± standard deviation. We used the independent Student‘s 
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t-test to compare the values of the means between cases and controls. 
Differences in categorical characteristics between cases and controls are 
assessed using x
2
-test. All statistical analysis are done using SPSS (version 
19.0). A p-value < 0.05 is considered statistically significant.  
 
Results: 
Anthropometric characteristics of PCOS cases and controls  
The women diagnosed with PCOS are between 18 and 33 years old. 
Mean age in PCOS group is 25.11 ± 3.32, and 25.10 ± 3.91 in the control 
group. BMI of the women with PCOS is found to be 23.44 ± 2.81, 
significantly higher BMI than the control group (p < 0.05). As it is expected, 
the waist-to-hip ratio is significantly higher in the case group (Table 1).   
 






Age 25.11 ± 3.32 25.10 ± 3.91 p=0.985 NS 
Weight 64.73 ± 8.45 55.00 ± 3.90 p=2.632
E-7 
S 
BMI 23.44 ± 2.81 20.22 ± 1.42 p=8.358
E-7 
S 
Waist 78.10 ± 2.40 70.87 ± 2.64 p=7.003
E-24 
S 
Hips 98.29 ± 2.14 92.17 ± 2.64 p=3.926
E-22 
S 




Prevalence of the diagnosis 
This study also found that from a total number of 70 women 
included, the higher percentage of PCOS patients are with oligomenorrhea 
45(64.3 %), with amenorrhea 5(7.1 %) and cases with regular menstrual 
cycle are 20 (28.6 %). (Figure 1) 
Figure 1.Distribution of women diagnosed with PCOS according to 
menstrual cycle 
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We defined hirsutism based on Ferriman-Gallwey index score (FG) 
of greater than 8 (Ferriman D et al, 1961), which is further divided into three 
categories : mild (FG 8-9) which in our study group is present in 30(42.9 %), 
moderate hirsutism (FG 10-14) present in 50% and 5 (7.1%) women 
diagnosed with PCOS showed hirsutism (FG>15). (Figure 2). 





As expected, we recorded significantly higher serum levels of LH, 
total testosterone (TT), and insulin, while the serum levels of SHBG and 
FSH are significantly lower than in the control group. The levels of LH/FSH 
ratio are significantly higher in the PCOS group when compared with the 
control group. The results are shown in Table 2. Values of glucose are within 
in normal limits in both groups of women, however values are significantly 
lower in the PCOS patient group. 
 
Table 2. Diffrences between biochemical and hormonal concentrations in 
PCOS and control group 
 Values in PCOS 
(mean±SD) 
Values in controls 
(mean±SD) 
Significance 
Glucose mmol/l 4.58 ± 0.52 5.08 ± 0.53 p=3.377E-5 S 
Insulin mIU/ml 11.59 ± 2.92 8.36 ±1.08 p=2.095E-12 S 
Total Testosterone (nmol/L) 2.15 ± 0.34 1.29 ±0.30 p=5.090
E-21 
S 
FSH mIU/ml 4.37 ± 0.53 5.13 ±0.34 p=3.264
E-13 
S 
LH mIU/ml 7.25 ± 0.68 4.37 ±0.63 p=4.192
E-36
 S 
LH/FSH 1.68 ± 0.26 0.85 ±0.14 p=2.682
E-15 
S 
SHBG nmol/l 48.76 ± 6.62 73.53 ±6.16 p=6.502
E-32 
S 
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Conclusion 
In the present study, we evaluated the clinical and biochemical 
characteristics of women with polycystic ovary syndrome in the region of 
Pollog, Republic of Macedonia. The advantage of our research is the fact that 
all ultrasound examinations are performed at one institution, with the same 
transvaginal ultrasound device, and by a physician who strictly kept to the 
Rotterdam criteria for the diagnosis of PCOS. In our study, among 70 
patients included, 42.9% had hirsutisms (FG 8-9), 50 % hirsutism (FG 10-
14) 7.1% of women diagnosed with PCOS showed hirsutism (FG>15). This 
is explained by the increased level of androgen which lead to increased 
secretion of testosterone, the causative agent of the appearance of male 
pattern (hirsutism). Effect od disease on menstrual cycle prevalence showed 
that the overall prevalence are 64.3 % out of women diagnosed with PCOS 
with oligomenorrhea, 7.1 % with amenorrhea and cases with regular 
menstrual cycle are 20 (28.6 %). 
In PCOS women, normal gonadotropin-ovarian axis is disturbed. 
This is reflected by the higher levels of LH, lower FSH levels and reversal of 
LH: FSH ratio. In our study, FSH level showed a significant difference 
(P<0.05) between PCOS patients and control, which is in agreement with 
previous studies (Eden J. et al, 1989), and it fits with the criteria for 
diagnosis of PCOS, where the levels of FSH hormone in PCOS patients and 
control group are within normal range. The level of LH is approximately 
more than two times of FSH level. These results agreed with previous studies 
(Atiomo W. et al, 2009), and with the criteria for diagnosis of PCOS. Finally 
serum testosterone showed highly significant difference between PCOS 
patients and the control group. 
By analyzing the clinical and biochemical characteristics of our 
studied population of patients with PCOS, we can conclude that the majority 
of our patients expressed all three diagnostic features of PCOS 
(hyperandrogenism, menstrual abnormalities, and ultrasound findings of 
polycystic ovaries).  
The available literature on PCOS emphasizes clinical and 
physiopathological aspects. Further studies encompassing sociocultural 
aspects of this syndrome must be carried out, focusing on questions related 
both to its causality and to its consequences on social trajectories, elements 
that may enrich the understanding of the phenomenon and its effect on the 
life of women affected by the syndrome.  
 
References: 
Knochenhauser ES, Key TJ, Kahsar-Miller M, Waggoner W,Boots LR, 
Azziz R. Prevalence of the polycystic ovary syndrome in unselected black 
European Scientific Journal   April 2014  edition vol.10, No.12   ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
185 
 
and white women of southeastern United States: a prospective study. J Clin 
Endocrinol Metab;83:3078-82, 1998. 
Eggers S, Kirchengast S, The Polycystic Ovary Syndrome –A Medical 
Condition but also an Important  Psychosocial Problem. Coll Antropol, 25 
673, 2001. 
Group PCW: Revised 2003 consensus on diagnostic criteria and long-term 
health risks related to polycystic ovary syndrome. Fertil Steril, 81(1):19–25, 
2004. 
Richardson MR, Current perspectives in polycystic ovary syndrome. Am 
Fam Physician, 68(4):697-704, 2003. 
Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing 
insulin resistance by simple quantitative methods in subjects with normal 
glucose metabolism. Diabetes Care. Dec;26(12):3320–3325, 2003. 
Azziz R, Carmina E, Dewailly D i sur. Positions statement: criteria for 
defining polycystic ovary syndrome as a predominantly hyperandrogenic 
syndrome: an Androgen Excess Society guideline. J Clin Endocrinol 
Metab;91:4237-45, 2006. 
Ferriman D, Gallwey JD "Clinical assessment of body hair growth in 
women". J. Clin. Endocrinol. Metab. 21 (11): 1440–7. doi:10.1210/jcem-21-
11-1440. PMID 1389257, 1961.  
Eden J., Place L., Carter G., Jones J., Pawson M.: The diagnosis of 
PCOS in subfertile women; Br. j. Obestet. Gynecol.;96:809-815, 1989. 
Atiomo W, Khalid S, Parameshweran S, Houda M, Layfield R.  
Proteomic biomarkers for the diagnosis and risk stratification of Polycystic 
Ovary Syndrome: a systematic review. BJOG 116: 137–143, 2009. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
